RPCEC00000099招募中4 期
Evaluation of effectiveness and safety of SURFACEN early use for the Newborn Respiratory Distress Syndrome. Phase IV
ational Center for Animal Plant and Health (CENSA)0 个研究点开始时间: 2011年4月18日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment
入排标准
- 年龄范围
- no 至 2 hours old(—)
- 性别
- All
入选标准
- •1. Newborn of less than 2 hours 2. Gestational age between 26-36 weeks, both inclusive 3. Patients who meet the criteria of early use of SURFACEN 4. Patient's mother (and/or Patient's father) who expressed voluntarily the participation in the study with the signature of the Informed Consent
排除标准
- •1. Major congenital malformations 2. Severe infections 3. Bronchoaspiration of the meconial amniotic liquid 4. Intrapartum asphyxia 5. Pneumothorax or pneumomediastinum before the beginning of the treatment with SURFACEN. 6. Pulmonary hemorrhage before the beginning of the treatment with SURFACE
研究者
相似试验
已完成
3 期
SURFACEN ARDS. Pediatrics. Phase IIIRespiratory distress syndrome in pediatric patientsRPCEC00000163ational Center for Animal and Plant Health (CENSA)72
已完成
2 期
SURFACEN in ARDS Adults. Phase IIAcute Respiratory Distress Syndrome in adultsRPCEC00000126ational Centre of Animal and Plants Health(CENSA)72
招募中
4 期
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extensioAcute Respiratory Distress Syndrome (ARDS)PediatricsRespiratory Distress Syndrome, AdultLung DiseasesRespiratory Tract DiseasesRespiration DisordersRPCEC00000253ational Center for Animal and Plant Health (CENSA)193
招募中
4 期
SURFACEN in ARDS. Adults. Phase IVAcute Respiratory Distress SyndromeRPCEC00000198ational Centre of Animal and Plants Health (CENSA)184
已完成
不适用
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944NL-OMON43676Vrije Universiteit Medisch Centrum33
